Year-over-year net earnings per share growth for the last 12 months: Retractable Technologies, Inc. (RVP)
Driven by US reshoring policies, Retractable Technologies (RVP) is shielded from external shocks, as evidenced by the quarterly growth in net income per share, which stands at 2036.50. Revenues are based on the sale of VanishPoint systems and self-destructing syringes. High efficiency is achieved through the total robotization of assembly lines and injection molding machines, which minimize manual labor.
Analytical breakdowns and data insights for company Retractable Technologies (RVP)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- book capitalization indicators:
- company total debt and liquidity indicators:
Debt to Equity Retractable Technologies|RVP - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital retractable.com|RVP - Company Cumulative Debt|Debt to Book Capitalization Ratio Retractable Tech|RVP - Company Long-Term Indebtedness|Company Current Liabilities Retractable Technologies|Quick Liquidity retractable.com
- earnings and market multiples details:
RVP - Net Financial Result|Expected Profit Retractable Technologies|RVP - Company Value to Net Income|Forward P/E Multiple retractable.com|RVP - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Retractable Tech|RVP - Company profit before taxes, interest and amortization|Earnings per share for the last twelve months Retractable Technologies|RVP - Earnings per share for the trailing year|Quarterly EPS earnings growth retractable.com|RVP - Earnings growth in current year|Earnings growth forecast for next year Retractable Technologies
Comprehensive company analysis:Retractable Technologies
This indicator reflects the dynamics of quarterly earnings per share (EPS) changes, allowing for the identification of business scaling trends prior to the publication of official financial statements and preventing overpayment for the asset. By analyzing the quarterly EPS growth index, an investor can see how clinic demand for Retractable Technologies (RVP) safe syringes converts into actual financial results, confirming the efficiency of the company's operating model.
Key competitors
Intuitive (ISRG) - Year-over-year earnings per share growth for the last twelve months|DHR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BDX|STE (STERIS Group) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months West Pharmaceutical Services (WST)|BAX (baxter.com) - Year-over-year earnings per one share growth for the last 12 months|Masimo - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Stevanato Group SpA STVN|TFX - Year-over-year earnings per share growth for the last twelve months|Merit Medical Corp (MMSI) - Year-over-year net earnings per share growth for the last 12 months|NVST: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months icumed.com (ICUI)|Year-over-year earnings per share growth for the last twelve months Dentsply Sirona|Year-over-year earnings per share growth for the last 12 months LMAT (LeMaitre Vascular Inc)|Year-over-year net earnings per share growth for the last 12 months ATRC (AtriCure Corp)|Year-over-year earnings per share growth rate for the last twelve months STAA|Year-over-year earnings per share growth for the last twelve months Chromadex Corp NAGE|Year-over-year net earnings per share change for the last twelve months zimvie.com (ZIMV)|ANGO - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months CERS (Cerus Corp.)|TKNO: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Monogram Orthopedics Inc. (MGRM)|Year-over-year net earnings per share growth for the last 12 months STSS|INFU (InfuSystem Inc) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Utah Medical Products, Inc. (UTMD)|KRMD (korumedical.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth NYXH (Nyxoah, S.A.)|Quarterly EPS earnings growth Microbot Medical, Inc MBOT|Pro-Dex, Inc. - Quarterly EPS earnings growth|zentek.com (ZTEK) - Year-over-year net earnings per share growth for the last 12 months|ELUT (Elutia) - Year-over-year net earnings per share growth for the last 12 months|MLSS: Year-over-year earnings per share growth rate for the last twelve months|NXGL (NEXGEL, Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Harvard Bioscience Inc.|Quarterly EPS earnings growth FEMY|Year-over-year earnings per share growth for the last twelve months MHUA (meihuamed.com)|Year-over-year earnings per share growth for the last twelve months Predictive Oncology Inc. POAI|Callan JMB Inc. - Year-over-year earnings per share growth for the last twelve months|Atrion Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroMetrix Corporation
